280 related articles for article (PubMed ID: 34197271)
1. Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.
Ngwa CH; Doungtsop BK; Bihnwi R; Ngo NV; Yang NM
Hum Vaccin Immunother; 2022 Dec; 18(1):1939620. PubMed ID: 34197271
[TBL] [Abstract][Full Text] [Related]
2. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Toor J; Li X; Jit M; Trotter CL; Echeverria-Londono S; Hartner AM; Roth J; Portnoy A; Abbas K; Ferguson NM; Am Gaythorpe K
Vaccine; 2022 Jul; 40(31):4142-4149. PubMed ID: 35672179
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Preventable Disease and Vaccine Hesitancy.
Hotez PJ
Med Clin North Am; 2023 Nov; 107(6):979-987. PubMed ID: 37806729
[TBL] [Abstract][Full Text] [Related]
5. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
Middeldorp M; van Lier A; van der Maas N; Veldhuijzen I; Freudenburg W; van Sorge NM; Sanders EAM; Knol MJ; de Melker HE
Vaccine; 2021 Feb; 39(7):1039-1043. PubMed ID: 33478793
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review of vaccine wastage and associated risk factors in the Littoral region of Cameroon during 2016-2017.
Nkenyi R; Pak GD; Tonga C; Chon Y; Park SE; Kang S
BMC Public Health; 2022 Oct; 22(1):1956. PubMed ID: 36274145
[TBL] [Abstract][Full Text] [Related]
7. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?
Frenkel LD
Allergy Asthma Proc; 2021 Sep; 42(5):378-385. PubMed ID: 34474707
[No Abstract] [Full Text] [Related]
8. Status of immunization and need for intensification of routine immunization in India.
Vashishtha VM
Indian Pediatr; 2012 May; 49(5):357-61. PubMed ID: 22700663
[TBL] [Abstract][Full Text] [Related]
9. Latin American forum on immunization services during the COVID-19 pandemic.
Ávila-Agüero ML; Ospina-Henao S; Pirez MC; Gentile Á; Araya S; Brea J; Mendoza L; Falleiros-Arlant LH
Expert Rev Vaccines; 2021 Mar; 20(3):231-234. PubMed ID: 33554682
[No Abstract] [Full Text] [Related]
10. Overview of the United States' Immunization Program.
Roper L; Hall MAK; Cohn A
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S443-S451. PubMed ID: 34590134
[TBL] [Abstract][Full Text] [Related]
11. The need for vaccination in adults with chronic (noncommunicable) diseases in India - lessons from around the world.
Vora A; Di Pasquale A; Kolhapure S; Agrawal A; Agrawal S
Hum Vaccin Immunother; 2022 Nov; 18(5):2052544. PubMed ID: 35416747
[TBL] [Abstract][Full Text] [Related]
12. System within systems: challenges and opportunities for the Expanded Programme on Immunisation in Pakistan.
Haq Z; Shaikh BT; Tran N; Hafeez A; Ghaffar A
Health Res Policy Syst; 2019 May; 17(1):51. PubMed ID: 31101060
[TBL] [Abstract][Full Text] [Related]
13. EPI immunization coverage, timeliness and dropout rate among children in a West Cameroon health district: a cross sectional study.
Ateudjieu J; Yakum MN; Goura AP; Tembei AM; Ingrid DK; Bita'a Landry B; Kenfack B; Amada L; Tadzong I; Bissek AC
BMC Public Health; 2020 Feb; 20(1):228. PubMed ID: 32054484
[TBL] [Abstract][Full Text] [Related]
14. Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.
Saidu Y; Gu J; Ngenge BM; Nchinjoh SC; Adidja A; Nnang NE; Muteh NJ; Zambou VM; Mbanga C; Agbor VN; Ousmane D; Njoh AA; Flegere J; Diack D; Wiwa O; Montomoli E; Clemens SAC; Clemens R
BMC Health Serv Res; 2023 Sep; 23(1):1033. PubMed ID: 37759205
[TBL] [Abstract][Full Text] [Related]
15. Implications of COVID-19 and "super floods" for routine vaccination in Pakistan: The reemergence of vaccine preventable-diseases such as polio and measles.
Ali I; Hamid S
Hum Vaccin Immunother; 2022 Dec; 18(7):2154099. PubMed ID: 36573023
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 on vaccination programs: adverse or positive?
Ali I
Hum Vaccin Immunother; 2020 Nov; 16(11):2594-2600. PubMed ID: 32961081
[TBL] [Abstract][Full Text] [Related]
17. Predictors to parental knowledge about childhood immunisation/EPI vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13).
Libwea JN; Kobela M; Ollgren J; Emah I; Tchio R; Nohynek H
Pan Afr Med J; 2014; 17():187. PubMed ID: 25396013
[TBL] [Abstract][Full Text] [Related]
18. Impact of social distancing on incidence of vaccine-preventable diseases, South Korea.
Yun HE; Ryu BY; Choe YJ
J Med Virol; 2021 Mar; 93(3):1814-1816. PubMed ID: 33079384
[TBL] [Abstract][Full Text] [Related]
19. Entangled epidemics: tackling vaccine-preventable diseases in the era of frequent epidemics in Africa.
Kouamou V; Inzaule S
Pan Afr Med J; 2023; 46():32. PubMed ID: 38145199
[TBL] [Abstract][Full Text] [Related]
20. Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America.
Avila Agüero ML; Castillo JBD; Falleiros-Arlant LH; Berezín E; de Moraes JC; Torres-Martínez C; Lopez EL; Castillo ME; Laris-Gonzalez A; Solorzano F; Gentile A; Torres Torretti JP; López-Medina E
Expert Rev Vaccines; 2023; 22(1):1091-1101. PubMed ID: 37843489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
